[BD »ç¾÷°³¹ß]´ëÇüÁ¦¾à»ç(¼­¿ï)

¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç

¸ðÁýºÎ¹® ´ã´ç¾÷¹« ÀÚ°Ý¿ä°Ç Àοø
BD

[´ã´ç¾÷¹«]

[¾÷¹«³»¿ë]
1) Portfolio Strategy & Product Planning
-ȸ»çÀÇ ÁßÀå±â Á¦Ç° Æ÷Æ®Æú¸®¿À Àü·« ¼ö¸³, ÇöÀç º¸À¯ Á¦Ç° ¹× °³¹ß ÆÄÀÌÇÁ¶óÀο¡ ´ëÇÑ Æ÷Æ®Æú¸®¿À ºÐ¼®
-Therapeutic Area ¹× ½ÃÀå ȯ°æÀ» °í·ÁÇÑ ½ÅÁ¦Ç° ¶óÀξ÷ Àü·« ±âȹ, ±¹³» ½ÃÀå °æÀï ȯ°æ ¹× ½ÃÀå ±Ô¸ð ºÐ¼®
2) Business Model Strategy: Á¦Ç° Ư¼º ¹× ½ÃÀå »óȲ¿¡ µû¸¥ »ç¾÷ ¸ðµ¨ ¼³°è, CSO Ȱ¿ë ¹× Co-promotion
3) Business Development & Negotiation: Co-promotion/partnership Çù»ó
4) Cross-functional Leadership: ¿µ¾÷, ¸¶ÄÉÆÃ, RA, °³¹ß Á¶Á÷°ú Çù¾÷ÇÏ¿© Á¦Ç° Àü·« ½ÇÇà

[ÀÚ°ÝÁ¶°Ç]
- ÇзÂ: 4³âÁ¦ Çлç ÀÌ»ó[¾àÇÐ, »ý¸í°úÇÐ, È­ÇÐ, °æ¿µ µî °ü·ÃÇаú Àü°ø]
- °æ·Â: ±¹³» Áß°ß Á¦¾à»ç Àü·«/Á¦Ç°±âȹ °æ·Â 5³â ÀÌ»ó~10³â ÀÌÇÏ
- ±¹³» ÀǾàǰ ½ÃÀå ¹× ¿µ¾÷ ±¸Á¶ ÀÌÇØ
- Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼® ¹× Àü·« ¼ö¸³ °æÇè
- °³·®½Å¾à ¹× ½ÅÁ¦Ç° ±âȹ ¹× °³¹ß °æÇè

[¿ì´ë»çÇ×]
- Therapeutic area Àü·« ¼ö¸³ °æÇè
- À繫 ºÐ¼® ¹× »ç¾÷¼º Æò°¡ °æÇè
- ¾à°¡ ¹× ƯÇã¾÷¹« °æÇèÀÚ
- ¿µ¾î´ÉÅëÀÚ

[ÀÚ°Ý¿ä°Ç]

°æ·Â: °æ·Â 5~10³â
ÇзÂ: ´ëÁ¹
Á÷¹«±â¼ú: BD, ÇØ¿Ü»ç¾÷ BD


0 ¸í

±Ù¹«Á¶°Ç

  • °í¿ëÇüÅÂ: Á¤±ÔÁ÷
  • ±Þ¿©Á¶°Ç: ȸ»ç³»±Ô

ÀüÇü´Ü°è ¹× Á¦Ãâ¼­·ù

  • ÀüÇü´Ü°è: ¼­·ùÀüÇü > ¸éÁ¢ÁøÇà > ÃÖÁ¾½É»ç > ÃÖÁ¾ÇÕ°Ý
  • Ãß°¡ Á¦Ãâ¼­·ù
    À̷¼­, ÀÚ±â¼Ò°³¼­

Á¢¼ö¹æ¹ý

  • Á¢¼ö¹æ¹ý: ÀÎÅ©·çÆ® Á¢¼ö
  • Á¢¼ö¾ç½Ä: ÀÎÅ©·çÆ® À̷¼­

±âŸ À¯ÀÇ»çÇ×

  • ÀÔ»çÁö¿ø¼­ ¹× Á¦Ãâ¼­·ù¿¡ ÇãÀ§»ç½ÇÀÌ ÀÖÀ» °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.

00